Robert M. Califf, MD, was sworn in as the new commissioner of the U.S. Food and Drug Administration (FDA) on February 17, 2022.
Previously, Dr. Califf served as FDA commissioner from February 2016–February 2017. Prior to rejoining the FDA, Dr. Califf was head of medical strategy and senior advisor at Alphabet Inc., contributing to strategy and policy for its health subsidiaries, Verily Life Sciences and Google Health. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute.
A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, health-care quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,300 publications in the peer-reviewed literature.
Dr. Califf will now oversee the federal agency tasked with finalizing and implementing over-the-counter hearing aid regulations.
Related Posts
Supplemental Benefits In Medicare Advantage (Hearing, Vision, Dental) Under Discussion
On November 4, the Medicare Payment Advisory Commission (MedPAC) discussed how to standardize a set of three or four benefits—potentially hearing, vision and dental services—in Medicare Advantage (MA) for a future recommendation to Congress after MedPAC staff found that people have a more challenging time comparing plans when they have a variety of options. MedPAC…
Academy Provides Recommendations to Congress on Reforming the Medicare Physician Payment System
The Academy submitted comments in response to a congressional Request for Information (RFI) seeking suggestions on how to stabilize the Medicare physician payment system, including reforming the current payment structure so it supports a system that provides greater value to patients and to clinicians. The Academy provided specific recommendations on the Medicare Physician Payment System…
Have You Heard?
An Update for Academy Members from the Academy’s Executive Director
By Patrick Gallagher, MBA, Executive Director Over-the-counter (OTC) hearing aids (HAs) became officially available on Monday, October 17, 2022, and their introduction has been met with much fanfare in the media. Within the Academy community, the reaction has been more measured. The Academy has recognized that OTC HAs may be a way for adults to…